Ana Šepac

659 total citations
17 papers, 505 citations indexed

About

Ana Šepac is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Ana Šepac has authored 17 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Ana Šepac's work include Cardiac Ischemia and Reperfusion (9 papers), Pluripotent Stem Cells Research (5 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Ana Šepac is often cited by papers focused on Cardiac Ischemia and Reperfusion (9 papers), Pluripotent Stem Cells Research (5 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Ana Šepac collaborates with scholars based in Croatia, United States and Austria. Ana Šepac's co-authors include Filip Sedlić, Zeljko J. Bosnjak, Stephen A. Duncan, Karim Si‐Tayeb, John Lough, Fallon K. Noto, Martin Bienengraeber, Tetsuro Wakatsuki, Amadou K.S. Camara and Danijel Pravdić and has published in prestigious journals such as International Journal of Molecular Sciences, Anesthesiology and American Journal of Physiology-Cell Physiology.

In The Last Decade

Ana Šepac

15 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Šepac Croatia 11 313 112 86 82 57 17 505
С. М. Минасян Russia 11 147 0.5× 145 1.3× 75 0.9× 96 1.2× 51 0.9× 40 397
Maryline Abrial France 14 497 1.6× 185 1.7× 52 0.6× 75 0.9× 21 0.4× 17 741
Heyangzi Li China 14 328 1.0× 163 1.5× 44 0.5× 110 1.3× 34 0.6× 17 653
Erzsébet Rőth Hungary 12 167 0.5× 70 0.6× 44 0.5× 155 1.9× 23 0.4× 36 435
Gianni Losano Italy 13 180 0.6× 121 1.1× 40 0.5× 146 1.8× 13 0.2× 20 528
J. Marc Simard United States 10 244 0.8× 129 1.2× 23 0.3× 88 1.1× 18 0.3× 12 511
Yuhei Saitoh Japan 11 132 0.4× 89 0.8× 23 0.3× 100 1.2× 19 0.3× 48 424
Jay Jayakumar United Kingdom 11 283 0.9× 161 1.4× 26 0.3× 113 1.4× 22 0.4× 22 533
G Losano Italy 10 130 0.4× 197 1.8× 87 1.0× 55 0.7× 28 0.5× 43 538
Shinji Okubo Japan 12 208 0.7× 430 3.8× 161 1.9× 88 1.1× 37 0.6× 20 669

Countries citing papers authored by Ana Šepac

Since Specialization
Citations

This map shows the geographic impact of Ana Šepac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Šepac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Šepac more than expected).

Fields of papers citing papers by Ana Šepac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Šepac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Šepac. The network helps show where Ana Šepac may publish in the future.

Co-authorship network of co-authors of Ana Šepac

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Šepac. A scholar is included among the top collaborators of Ana Šepac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Šepac. Ana Šepac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Šiljeg, Mario, Davor Miličić, Hrvoje Gašparović, et al.. (2024). Cardiotoxicity of Iron and Zinc and Their Association with the Mitochondrial Unfolded Protein Response in Humans. International Journal of Molecular Sciences. 25(17). 9648–9648.
2.
Sikirić, Sunčana, Marija Milavić, Ana Šepac, et al.. (2023). Heart failure in patients is associated with downregulation of mitochondrial quality control genes. European Journal of Clinical Investigation. 53(11). e14054–e14054. 20 indexed citations
3.
Šepac, Ana, et al.. (2021). Human C2a and C6a iPSC lines and H9 ESC line have less efficient cardiomyogenesis than H1 ESC line: Beating enhances cardiac differentiation. The International Journal of Developmental Biology. 65(10-11-12). 537–543. 1 indexed citations
4.
Sedlić, Filip, Ana Šepac, Sunčana Sikirić, et al.. (2020). Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG. Antioxidants. 9(7). 606–606. 9 indexed citations
5.
Šepac, Ana, Davor Miličić, Joško Bulum, et al.. (2020). Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart. Croatian Medical Journal. 61(2). 126–138. 30 indexed citations
7.
Brčić, Luka, Božo Krušlin, Ana Šepac, et al.. (2018). Expression of plakophilin 3 in diffuse malignant pleural mesothelioma.. PubMed. 33(9). 995–1004. 3 indexed citations
8.
Sedlić, Filip, Maria Muravyeva, Ana Šepac, et al.. (2016). Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning. Journal of Cellular Physiology. 232(1). 216–224. 25 indexed citations
9.
Brčić, Luka, Marko Jakopović, Iva Brčić, et al.. (2014). Reproducibility of histological subtyping of malignant pleural mesothelioma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(6). 679–685. 18 indexed citations
10.
Canfield, Scott G., Ana Šepac, Filip Sedlić, et al.. (2012). Marked Hyperglycemia Attenuates Anesthetic Preconditioning in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes. Anesthesiology. 117(4). 735–744. 36 indexed citations
11.
Šepac, Ana, Karim Si‐Tayeb, Filip Sedlić, et al.. (2012). Comparison of Cardiomyogenic Potential among Human ESC and iPSC Lines. Cell Transplantation. 21(11). 2523–2530. 27 indexed citations
12.
Oh, Ah‐Young, et al.. (2011). Isoflurane decreases death of human embryonic stem cell-derived, transcriptional marker Nkx2.5+ cardiac progenitor cells. Acta Anaesthesiologica Scandinavica. 55(9). 1124–1131. 13 indexed citations
13.
Šepac, Ana, Filip Sedlić, Karim Si‐Tayeb, et al.. (2010). Isoflurane Preconditioning Elicits Competent Endogenous Mechanisms of Protection from Oxidative Stress in Cardiomyocytes Derived from Human Embryonic Stem Cells. Anesthesiology. 113(4). 906–916. 42 indexed citations
14.
Sedlić, Filip, Danijel Pravdić, Naoyuki Hirata, et al.. (2010). Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1797(10). 1749–1758. 22 indexed citations
15.
Si‐Tayeb, Karim, Fallon K. Noto, Ana Šepac, et al.. (2010). Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Developmental Biology. 10(1). 81–81. 177 indexed citations
16.
Sedlić, Filip, Ana Šepac, Danijel Pravdić, et al.. (2010). Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+. American Journal of Physiology-Cell Physiology. 299(2). C506–C515. 72 indexed citations
17.
Pravdić, Danijel, Filip Sedlić, Ana Šepac, & Zeljko J. Bosnjak. (2008). Anesthetic-induced cardiac preconditioning. 40. 37–43.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026